Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases
- PMID: 32508059
- PMCID: PMC7240871
- DOI: 10.1002/ctm2.2
Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases
Abstract
Chronic lung diseases represent a largely global burden whose pathogenesis remains largely unknown. Research increasingly suggests that epigenetic modifications, especially DNA methylation, play a mechanistic role in chronic lung diseases. DNA methylation can affect gene expression and induce various diseases. Of the caveolae in plasma membrane of cell, caveolin-1 (Cav-1) is a crucial structural constituent involved in many important life activities. With the increasingly advanced progress of genome-wide methylation sequencing technologies, the important impact of Cav-1 DNA methylation has been discovered. The present review overviews the biological characters, functions, and structure of Cav-1; epigenetic modifications of Cav-1 in health and disease; expression and regulation of Cav-1 DNA methylation in the respiratory system and its significance; as well as clinical potential as disease-specific biomarker and targets for early diagnosis and therapy.
Keywords: caveolae; caveolin-1; chronic lung diseases; epigenetic modification; methylation.
© 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Cohen AW, Hnasko R, Schubert W, Lisanti MP, Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84:1341‐1379. - PubMed
-
- Galbiati F, Engelman JA, Volonte D, et al. Caveolin‐3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin‐glycoprotein complex, and t‐tubule abnormalities. J Biol Chem. 2001;276:21425‐21433. - PubMed
Publication types
LinkOut - more resources
Full Text Sources